RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing oral therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
Total raised: $86M
Founded date: 2015
Investors 5
| Date | Name | Website |
| 13.07.2025 | Foresite C... | foresiteca... |
| - | The Column... | thecolumng... |
| - | Accel Part... | accel.com |
| - | Solasta Ve... | solasta-ve... |
| 10.07.2021 | GV | gv.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.07.2019 | IPO | $86M | - |
Mentions in press and media 8
| Date | Title | Description |
| 20.01.2026 | GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair | - |
| 07.03.2024 | RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results | - |
| 05.03.2024 | RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting | - |
| 25.05.2022 | RAPT Therapeutics Announces Private Placement Financing of $50 Million | SOUTH SAN FRANCISCO, Calif., May 25, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule th... |
| 14.03.2008 | Microsoft Picks Up Another Ad Startup: Rapt | Will Microsoft’s hunger for advertising startups sever be satiated? Even as it continues to pursue the big Yahoo merger, it keeps picking up small startups to fill out its advertising software business. A couple weeks ago it was micro-segme... |
| 15.09.2006 | Rapt, Accel & Levensohn settle with co-founders in ten days | Just ten days after two co-founders of San Francisco pricing software company Rapt sued its venture backers, the case has been settled. We thought it would be quick (see our original story here), because high-profile venture firm Accel Part... |
| 06.09.2006 | Rapt co-founders sue Accel & Levensohn for playing hardball | Two co-founders of Rapt have sued the company’s chief executive and venture capital backers, Accel Partners and Levensohn Venture Partners for breach of fiduciary duty and fraud. Rapt is a San Francisco company that provides software to hel... |
| - | Congratulations RAPT Therapeutics - Harnessing the human immune system to treat cancer and inflammatory diseases | RAPT Therapeutics' journey began in 2013 when Kleiner Perkins incubated a company known as Flexus Bioscience to develop novel small molecule therapies to treat cancer and drugs for debilitating inflammatory diseases. Small molecule therapie... |